These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
693 related articles for article (PubMed ID: 28560754)
1. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts. Hergovits S; Mais C; Haan C; Costa-Pereira AP; Hermanns HM J Cell Mol Med; 2017 Nov; 21(11):3087-3099. PubMed ID: 28560754 [TBL] [Abstract][Full Text] [Related]
2. IRF-1, RIG-I and MDA5 display potent antiviral activities against norovirus coordinately induced by different types of interferons. Dang W; Xu L; Yin Y; Chen S; Wang W; Hakim MS; Chang KO; Peppelenbosch MP; Pan Q Antiviral Res; 2018 Jul; 155():48-59. PubMed ID: 29753657 [TBL] [Abstract][Full Text] [Related]
3. The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer. Shu XS; Zhao Y; Sun Y; Zhong L; Cheng Y; Zhang Y; Ning K; Tao Q; Wang Y; Ying Y J Pathol; 2018 Jan; 244(1):36-48. PubMed ID: 28940253 [TBL] [Abstract][Full Text] [Related]
4. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2. Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430 [TBL] [Abstract][Full Text] [Related]
5. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells. Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between different family members: IL27 recapitulates IFNγ responses in HCC cells, but is inhibited by IL6-type cytokines. Rolvering C; Zimmer AD; Kozar I; Hermanns HM; Letellier E; Vallar L; Nazarov PV; Nicot N; Ginolhac A; Haan S; Behrmann I; Haan C Biochim Biophys Acta Mol Cell Res; 2017 Mar; 1864(3):516-526. PubMed ID: 27939431 [TBL] [Abstract][Full Text] [Related]
7. Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome. Cao Z; Zhou Y; Zhu S; Feng J; Chen X; Liu S; Peng N; Yang X; Xu G; Zhu Y Sci Rep; 2016 Feb; 6():22002. PubMed ID: 26906558 [TBL] [Abstract][Full Text] [Related]
8. Involvement of tyrosine phosphatase PTP1D in the inhibition of interleukin-6-induced Stat3 signaling by alpha-thrombin. Gunaje JJ; Bhat GJ Biochem Biophys Res Commun; 2001 Oct; 288(1):252-7. PubMed ID: 11594781 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells. Yen JH; Kong W; Hooper KM; Emig F; Rahbari KM; Kuo PC; Scofield BA; Ganea D J Leukoc Biol; 2015 Nov; 98(5):689-702. PubMed ID: 26059829 [TBL] [Abstract][Full Text] [Related]
10. A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination. Min YQ; Ning YJ; Wang H; Deng F J Biol Chem; 2020 Jul; 295(28):9691-9711. PubMed ID: 32471869 [TBL] [Abstract][Full Text] [Related]
11. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass. Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849 [TBL] [Abstract][Full Text] [Related]
12. RIG-I enhances interferon-α response by promoting antiviral protein expression in patients with chronic hepatitis B. Wu S; Lin J; Fu Y; Ou Q Antivir Ther; 2018; 23(7):575-583. PubMed ID: 29790851 [TBL] [Abstract][Full Text] [Related]
13. Distinctive pro-inflammatory gene signatures induced in articular chondrocytes by oncostatin M and IL-6 are regulated by Suppressor of Cytokine Signaling-3. Liu X; Liu R; Croker BA; Lawlor KE; Smyth GK; Wicks IP Osteoarthritis Cartilage; 2015 Oct; 23(10):1743-54. PubMed ID: 26045176 [TBL] [Abstract][Full Text] [Related]
14. RIG-I like receptor sensing of host RNAs facilitates the cell-intrinsic immune response to KSHV infection. Zhao Y; Ye X; Dunker W; Song Y; Karijolich J Nat Commun; 2018 Nov; 9(1):4841. PubMed ID: 30451863 [TBL] [Abstract][Full Text] [Related]
15. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway. Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102 [TBL] [Abstract][Full Text] [Related]
16. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361 [TBL] [Abstract][Full Text] [Related]
17. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture. Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178 [TBL] [Abstract][Full Text] [Related]
18. Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor. Persson E; Souza PPC; Floriano-Marcelino T; Conaway HH; Henning P; Lerner UH Front Immunol; 2019; 10():1164. PubMed ID: 31191537 [No Abstract] [Full Text] [Related]
19. Spatiotemporal dynamics of innate immune signaling via RIG-I-like receptors. Esser-Nobis K; Hatfield LD; Gale M Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15778-15788. PubMed ID: 32571931 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation. Liu X; Sadaoka T; Krogmann T; Cohen JI J Virol; 2020 May; 94(11):. PubMed ID: 32213613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]